Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel dual PPAR agonist with hypoglycemic and hypolipidemic effects

June 15, 2004

Results of phase III trials of rimonabant in metabolic syndrome and smoking presented

June 15, 2004

Long-acting dipeptidyl-peptidase IV inhibitor ameliorates insulin resistance

June 15, 2004

Sanwa Kagaku presents GLP-1 analogues suitable for oral or intranasal administration

June 14, 2004

New and unique oral delivery system, CAPIC particles, for insulin and other macromolecules

June 14, 2004

NeuroSearch and Rheoscience collaborate in obesity

June 14, 2004

Positive opinion for Apidra in E.U.

June 14, 2004

Triazole-based vasopressin V1a antagonists and their use in dysmenorrhea therapy

June 11, 2004

Axokine benefits overweight, diabetic patients

June 11, 2004

Liraglutide reduces body weight in preclinical and clinical studies

June 11, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...